While ongoing monitoring of calcitonin during GLP-1 therapy is not standard practice, patients should receive education about thyroid cancer warning signs and the importance of reporting new symptoms
So patients, if theyre doing well and if theyre responding, you can imagine they want to retain coverage of the medication
The medication has garnered substantial attention not only for its effectiveness in managing diabetes but also for its remarkable weight loss benefits
When you take Foundayo, the medication binds to GLP-1 receptors in the brain and gut, which can help: Reduce overall hunger and the frequency of food cravings Increase the feeling of fullness after meals Slow gastric emptying, so meals leave you feeling satisfied for longer Support more stable blood-sugar levels throughout the day What makes Foundayo different from older oral options is that it is a small-molecule compound rather than a peptide
Nevertheless, commenting on the work, Professor David Attwell, Jodrell professor of physiology at UCL and study co-lead, said: With an increasing number of similar GLP-1 drugs now being used in clinical practice, for conditions ranging from type 2 diabetes and obesity to kidney disease, our findings highlight the potential for these existing drugs to be repurposed to treat the risk of no-reflow in [myocardial infarction] patients, offering a potentially life-saving solution. Reference Mastitskaya S et al
They can help you figure out whats best for your health and your goals